Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mirati Announces Collaboration with Bristol-Myers Squibb for Sitravatinib, OPDIVO Trial

americanpharmaceuticalreviewJanuary 09, 2019

Tag: Mirati , Bristol-Myers Squibb , sitravatinib , OPDIVO Trial

PharmaSources Customer Service